معرفی
Dr. Lara Herrero is an Associate Professor at Griffith University's Institute for Biomedicine and Glycomics and NHMRC Research Fellow, specializing in glycobiology of vector-borne diseases. Medically and scientifically trained, her research focuses on alphavirus-induced arthritis and immunomodulatory therapies, including the repurposing of pentosan polysulfate for viral arthritis treatment.
Research examines:
- Carbohydrate-virus-cell interactions in pathogenesis
- Mouse models of alphaviral disease
- Glycotherapeutic strategies for musculoskeletal infections
- TRIF-dependent antiviral responses
- Long COVID immune dysregulation
Notably developed the first treatment for alphaviral arthritis through drug repurposing, now in clinical use via Paradigm Biopharmaceuticals. Awarded the 2023 Prime Minister's Prize for Science (New Innovators) and named Griffith University's top contributor to The Conversation with 5.4M+ article reads.
Leads projects on ME/CFS/Long COVID immunology funded by Stafford Fox Foundation ($6.4M) and NHMRC synergy grants. Mentors doctoral candidates in virology and immunology.
